These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9829156)

  • 1. Dienogest.
    Foster RH; Wilde MI
    Drugs; 1998 Nov; 56(5):825-33; discussion 834-5. PubMed ID: 9829156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens with antiandrogenic properties.
    Raudrant D; Rabe T
    Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethinylestradiol/dienogest in oral contraception.
    Pérez-Campos EF
    Drugs; 2010 Apr; 70(6):681-9. PubMed ID: 20394455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
    Golbs S; Domhardt R; Radowicky S; Kałuzny Z; Wisser KH; Zimmermann T
    Methods Find Exp Clin Pharmacol; 2002 Nov; 24(9):585-92. PubMed ID: 12616705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL; Rose R
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dienogest: a review of its use in the treatment of endometriosis.
    McCormack PL
    Drugs; 2010 Nov; 70(16):2073-88. PubMed ID: 20964453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
    Rabe T; Kowald A; Ortmann J; Rehberger-Schneider S
    Gynecol Endocrinol; 2000 Aug; 14(4):223-30. PubMed ID: 11075290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antiandrogens in hormone replacement therapy.
    Schneider HP
    Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of dienogest.
    Ruan X; Seeger H; Mueck AO
    Maturitas; 2012 Apr; 71(4):337-44. PubMed ID: 22364708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of newer progestogens.
    Kuhl H
    Drugs; 1996 Feb; 51(2):188-215. PubMed ID: 8808163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol valerate/dienogest.
    Wellington K; Perry CM
    Drugs; 2002; 62(3):491-504; discussion 505-6. PubMed ID: 11827562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
    Katsuki Y; Sasagawa S; Takano Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
    Drugs Exp Clin Res; 1997; 23(2):45-62. PubMed ID: 9309380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The endocrinologic profile of metabolites of the progestin dienogest].
    Oettel M; Kaufmann G; Kurischko A
    Pharmazie; 1993 Jul; 48(7):541-5. PubMed ID: 8415850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medication of the month. A new combined oral contraceptive containing estradiol valerate and dienogest (Qlaira)].
    Gaspard U; Pintiaux A; Kridelka F
    Rev Med Liege; 2010 Dec; 65(12):706-13. PubMed ID: 21287768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.
    Golbs S; Domhardt R; Presl J; Ganev M; Wisser KH; Zimmermann T
    Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):689-96. PubMed ID: 12616963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationale for prescribing oral contraceptives].
    Teichmann AT
    Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
    Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of a new monophasic oral contraceptive on body metabolism].
    Radowicki S; Skórzewska K; Borakowska B
    Ginekol Pol; 2003 Sep; 74(9):1002-7. PubMed ID: 14674159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.